CIK 0001384101 · Large accelerated filer
VERACYTE, INC.
Sign in to watch- Ticker
- VCYT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205455398
- Phone
- (650) 243-6300
- Business address
- 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CALDEROME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,858,989
- in 9 filings, $2.9M under 10b5-1 plans
Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Leite John Chief Commercial Officer-CLIA | Sale 10b5-1 | −1,278 | $47.51 | $61K | 82,113 |
| 2025-12-04 | McGuire Annie SVP, General Counsel | Sale 10b5-1 | −720 | $47.10 | $34K | 79,201 |
| 2025-12-04 | McGuire Annie SVP, General Counsel | Sale 10b5-1 | −702 | $47.51 | $33K | 78,499 |
| 2025-12-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −8,537 | $46.61 | $398K | 114,237 |
| 2025-12-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −4,741 | $47.25 | $224K | 109,496 |
| 2025-12-04 | Stapley Marc Chief Executive Officer | Sale 10b5-1 | −4,448 | $46.90 | $209K | 321,823 |
| 2025-12-04 | Stapley Marc Chief Executive Officer | Sale 10b5-1 | −3,220 | $47.35 | $152K | 318,603 |
| 2025-12-02 | Leite John Chief Commercial Officer-CLIA | Shares withheld for taxes 10b5-1 | −2,900 | $46.16 | $134K | 83,391 |
| 2025-12-02 | McGuire Annie SVP, General Counsel | Shares withheld for taxes 10b5-1 | −3,052 | $46.16 | $141K | 79,921 |
| 2025-12-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,384 | $46.16 | $156K | 122,774 |
| 2025-12-02 | Febbo Phillip G. Chief Scientific & Med Officer | Shares withheld for taxes | −2,955 | $46.16 | $136K | 89,486 |
| 2025-12-02 | Wygant Jonathan VP, Chief Accounting Officer | Shares withheld for taxes | −1,325 | $46.16 | $61K | 37,420 |
| 2025-12-02 | Stapley Marc Chief Executive Officer | Shares withheld for taxes 10b5-1 | −7,914 | $46.16 | $365K | 326,271 |
| 2025-11-25 | Leite John Chief Commercial Officer-CLIA | Sale 10b5-1 | −2,808 | $50.00 | $140K | 86,291 |
| 2025-11-25 | JONES EVAN/ FA Director | Sale 10b5-1 | −1,106 | $50.25 | $56K | 29,362 |
| 2025-11-20 | Holstein Jens Director | Sale 10b5-1 | −1,491 | $40.95 | $61K | 35,708 |
| 2025-11-20 | Holstein Jens Director | Sale 10b5-1 | −7,049 | $42.48 | $299K | 28,659 |
| 2025-11-20 | Holstein Jens Director | Sale 10b5-1 | −1,460 | $43.21 | $63K | 27,199 |
| 2025-11-10 | Wygant Jonathan VP, Chief Accounting Officer | Sale | −5,102 | $42.33 | $216K | 38,745 |
| 2025-11-07 | Wygant Jonathan VP, Chief Accounting Officer | Sale | −5,818 | $40.21 | $234K | 43,847 |
Page 6 of 9 · 168 trades